Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Berek

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 16, 2020
Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
CNS Drugs|September 29, 2022
Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving NatalizumabMichael Auer, Angelika Bauer, Antonia Oftring, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosisGabriel Bsteh, Klaus Berek, Harald Hegen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 22, 2019
Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MSGabriel Bsteh, Ruth Steiger, Noora Tuovinen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2022
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosisKlaus Berek, Harald Hegen, Jakob Hocher, et al.
Brain and Behavior|November 18, 2024
Neurofilament Light Chain Is Associated With Acute Mountain SicknessKlaus Berek, Anna Lindner, Franziska Di Pauli, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Serum hepcidin levels in multiple sclerosisGabriel Bsteh, David Haschka, Piotr Tymoszuk, et al.
Frontiers in Immunology|November 5, 2021
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an AssociationFranziska Di Pauli, Paul Morschewsky, Klaus Berek, et al.
Frontiers in Immunology|December 1, 2022
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorderAngelika Bauer, Dagmar Rudzki, Klaus Berek, et al.
European Journal of Neurology|March 18, 2021
Retinal layer thinning predicts treatment failure in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 16, 2020
Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
CNS Drugs|September 29, 2022
Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving NatalizumabMichael Auer, Angelika Bauer, Antonia Oftring, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosisGabriel Bsteh, Klaus Berek, Harald Hegen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 22, 2019
Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MSGabriel Bsteh, Ruth Steiger, Noora Tuovinen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2022
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosisKlaus Berek, Harald Hegen, Jakob Hocher, et al.
Brain and Behavior|November 18, 2024
Neurofilament Light Chain Is Associated With Acute Mountain SicknessKlaus Berek, Anna Lindner, Franziska Di Pauli, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Serum hepcidin levels in multiple sclerosisGabriel Bsteh, David Haschka, Piotr Tymoszuk, et al.
Frontiers in Immunology|November 5, 2021
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and Varicella Zoster Virus Infection - Frequency of an AssociationFranziska Di Pauli, Paul Morschewsky, Klaus Berek, et al.
Frontiers in Immunology|December 1, 2022
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorderAngelika Bauer, Dagmar Rudzki, Klaus Berek, et al.
European Journal of Neurology|March 18, 2021
Retinal layer thinning predicts treatment failure in relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Pageof 10